Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice
- PMID: 1437655
- DOI: 10.1080/01635589209514218
Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice
Abstract
Ellagic acid (EA), derived from fruit ellagitannins, is known to be antimutagenic and anticarcinogenic in various animal tumor models. In this study, EA at a dose of 4 g/kg diet inhibited multiplicity of tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mice by 54%. This inhibition was dose related between 0.06 and 4.0 g/kg diet. In contrast, two related compounds, esculin and esculetin, had no effect on lung tumorigenesis. The biodistribution of EA was studied as a function of dose and time after gavage of EA. The levels of EA in the lung were directly proportional to the dose of EA between 0.2 and 2.0 mmol. The maximum level of EA, corresponding to 21.3 nmol/g, was observed 30 minutes after gavage with 2.0 mmol of EA/kg body wt, which corresponds to only 70 ppm of the administered dose. The levels in liver tissues were 10-fold lower and reached a maximum 30 minutes after gavage. At this interval, the blood level of EA was 1 nmol/ml. The inclusion of EA in cyclodextrin doubles the level of EA in lung tissues. These results demonstrate that EA localizes preferentially in lung tissues and confirm that EA administered orally can inhibit lung tumorigenesis.
Similar articles
-
Biodistribution of, antimutagenic efficacies in Salmonella typhimurium of, and inhibition of P450 activities by ellagic acid and one analogue.Chem Res Toxicol. 1998 Nov;11(11):1258-64. doi: 10.1021/tx980033g. Chem Res Toxicol. 1998. PMID: 9815185
-
Pulmonary carcinogenesis and its prevention by dietary polyphenolic compounds.Ann N Y Acad Sci. 1993 May 28;686:177-85. doi: 10.1111/j.1749-6632.1993.tb39172.x. Ann N Y Acad Sci. 1993. PMID: 8512246
-
Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice.Cancer Res. 1990 May 1;50(9):2613-7. Cancer Res. 1990. PMID: 2328487
-
Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers.Nanotechnology. 2020 Sep 18;31(38):382001. doi: 10.1088/1361-6528/ab912c. Epub 2020 May 7. Nanotechnology. 2020. PMID: 32380485 Review.
-
Metabolic fate of ellagitannins: implications for health, and research perspectives for innovative functional foods.Crit Rev Food Sci Nutr. 2014;54(12):1584-98. doi: 10.1080/10408398.2011.644643. Crit Rev Food Sci Nutr. 2014. PMID: 24580560 Review.
Cited by
-
Chitosan-Based Microparticles Enhance Ellagic Acid's Colon Targeting and Proapoptotic Activity.Pharmaceutics. 2020 Jul 9;12(7):652. doi: 10.3390/pharmaceutics12070652. Pharmaceutics. 2020. Retraction in: Pharmaceutics. 2024 Jan 30;16(2):196. doi: 10.3390/pharmaceutics16020196. PMID: 32660035 Free PMC article. Retracted.
-
In Vivo Metabolite Profiling of a Purified Ellagitannin Isolated from Polygonum capitatum in Rats.Molecules. 2016 Aug 24;21(9):1110. doi: 10.3390/molecules21091110. Molecules. 2016. PMID: 27563862 Free PMC article.
-
Method development and validation for pharmacokinetic and tissue distributions of ellagic acid using ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).Molecules. 2014 Nov 18;19(11):18923-35. doi: 10.3390/molecules191118923. Molecules. 2014. PMID: 25412040 Free PMC article.
-
Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals.Eur J Drug Metab Pharmacokinet. 1999 Apr-Jun;24(2):183-9. doi: 10.1007/BF03190367. Eur J Drug Metab Pharmacokinet. 1999. PMID: 10510748 Review.
-
A Critical Appraisal of Solubility Enhancement Techniques of Polyphenols.J Pharm (Cairo). 2014;2014:180845. doi: 10.1155/2014/180845. Epub 2014 Mar 3. J Pharm (Cairo). 2014. PMID: 26556188 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical